| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Seres Therapeutics, Inc. (MCRB) has 9 insiders with recent SEC Form 4 filings, including 2 buys and 12 sells. MCRB is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 56.3K | $371.3K | - | |
| Other | 22.5K | $148.5K | - | |
| Dir | 11.5K | $75.7K | - | |
| Dir | 11.0K | $72.6K | - | |
| Dir | 10.0K | $66.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2019 | Afeyan Noubar74 | Director, 10% Owner | Buy | 8,888,888 | $2.25 | $19,999,998.00 | New | |
| Jan 28, 2019 | Desrosier Thomas66 | Chief Legal Officer And EVP | Sale+OE | 5,471 | $5.75 | $31,477.95 | -25.4% | |
| Jan 28, 2019 | Shaff Eric D.66 | See Remarks | Sale+OE | 4,378 | $5.75 | $25,187.51 | -25.4% | |
| Dec 17, 2018 | Aunins John G. | Chief Technology Officer &EVP | Sale+OE | 14,282 | $6.39 | $91,313.40 | -16.0% | |
| Nov 15, 2018 | Aunins John G. | See Remarks | Sell | 14,279 | $8.26 | $117,911.70 | -13.8% | |
| Oct 15, 2018 | Aunins John G. | See Remarks | Sell | 14,279 | $5.94 | $84,800.13 | -12.1% | |
| Sep 17, 2018 | Aunins John G. | See Remarks | Sell | 42,837 | $7.64 | $327,344.65 | -9.7% | |
| Sep 7, 2018 | Pomerantz Roger | President And CEO | Sell | 1,810 | $9.00 | $16,291.27 | -0.8% | |
| Sep 6, 2018 | Pomerantz Roger | President And CEO | Sell | 12,518 | $9.10 | $113,949.53 | -2.8% | |
| Jul 15, 2018 | Aunins John G. | Chief Technology Officer &EVP | Sell | 14,279 | $8.10 | $115,725.58 | -8.1% |